Showing 5081-5090 of 5644 results for "".
- Occupational Radiation Exposure Tied to Higher Cataract Riskhttps://modernod.com/news/occupational-radiation-exposure-tied-to-higher-cataract-risk/2477191/Higher cumulative occupational exposure to low-dose radiation is associated with excess additive risk (EAR) of developing cataract, according to a new study in a large prospective cohort of U.S. radiation technologists, Reuters reported. <
- Nicox’s NCX 4251 Meets Primary Endpoint in Phase 2 Blepharitis Trial and Shows Promising Efficacy in Dry Eye Diseasehttps://modernod.com/news/nicoxs-ncx-4251-meets-primary-endpoint-in-phase-2-blepharitis-trial-and-shows-promising-efficacy-in-dry-eye-disease/2477187/Nicox SA announced that NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, has met the primary objective of its U.S. multicenter, dose escalating, first-in-human, phase 2 clinical trial (referred to as ‘Danube’) evaluating the safety and tolerability of NCX 4
- Midwest Vision Partners Announces Partnership With Cleveland Eye Clinichttps://modernod.com/news/midwest-vision-partners-announces-partnership-with-cleveland-eye-clinic/2477186/Eye care management company Midwest Vision Partners (MVP) has announced its partnership with Cleveland Eye Clinic (CEC). Terms of the deal were not disclosed. MVP’s partnership with CEC expands its network to 19 locations in Ohio with 33 physicians providing medical and surgic
- Trump Administration Advances Plan to Allow Certain Prescription Drug Imports From Canadahttps://modernod.com/news/trump-administration-advances-plan-to-allow-certain-prescription-drug-imports-from-canada/2477183/The US Department of Health and Human Services (HHS) said the Trump administration is pushing ahead with a plan to allow certain prescription drugs to be imported from Canada. “For the first time in history HHS and FDA are open to importation as a means for lower prices,” co
- ProtoKinetix AAGP Retinal Cell Replacement Therapy Testing at UBC Completedhttps://modernod.com/news/protokinetix-aagp-retinal-cell-replacement-therapy-testing-at-ubc-completed/2477184/ProtoKinetix announced the completion of an in vivo study to assess the effect of AAGP on the long term survival and functional activity of photoreceptor precursor cells (PPCs) in the animal ocular model of genetic retinal degeneration. The objective of this study was to determine t
- 1-800 Contacts Enters Agreement to Acquire Vision Start-Up 6over6 Visionhttps://modernod.com/news/1-800-contacts-enters-agreement-to-acquire-vision-start-up-6over6-vision/2477177/1-800 Contacts announced that it entered into a definitive agreement to acquire 6over6 Vision (6over6), a provider of at-home vision tests using a mobile app or computer. Terms of the deal were not disclosed. 6over6 currently offers a vari
- FFL Partners To Sell EyeCare Partners to Partners Group Holdinghttps://modernod.com/news/ffl-partners-to-sell-eyecare-partners/2477173/Private Equity Firm FFL Partners has has signed a definitive agreement to sell EyeCare Partners (ECP), the largest medically focused and integrated eye care services provider in the US, to Partners Group Holding. While financial terms of the deal were not disclosed, The Wall Street Jou
- FDA Advisory Committee Votes Unanimously to Support the Use of Teprotumumab for the Treatment of Thyroid Eye Disease (TED)https://modernod.com/news/fda-advisory-committee-votes-unanimously-to-support-the-use-of-teprotumumab-for-the-treatment-of-thyroid-eye-disease-ted/2477171/Horizon Therapeutics announced that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the FDA voted unanimously that the potential benefits of teprotumumab, a fully human monoclonal antibody (mAb), outweigh the potential risks for the treatment of Thyroid Eye Disease (TED).
- Horizon Therapeutics Trading Halted Today; FDA Committee Meeting to Discuss Teprotumumab for Thyroid Eye Diseasehttps://modernod.com/news/horizon-therapeutics-trading-halted-today-fda-committee-meeting-to-discuss-teprotumumab-for-thyroid-eye-disease/2477167/Horizon Therapeutics announced that NASDAQ has halted trading of the company’s common stock, listed as HZNP. As per the FDA guidelines for new molecular entities (NMEs), the FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) is holding a meeting today from 8 am to 4 pm ET to discuss
- Stephen Hahn Confirmed as New FDA Chiefhttps://modernod.com/news/stephen-hahn-confirmed-as-new-fda-chief/2477168/The US Senate voted 72 to 18 on Thursday to confirm President Donald Trump nominee Stephen Hahn as the next FDA Commissioner. The radiation oncologist, who was recently cleared by the Senate Health, Education, Labor and Pensions Committee, replaces Scott Gottlieb, who stepped down in Ap